Berns Paul L

Berns Paul L is listed in filings as See Remarks at Neumora Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through Feb 19, 2026, including sale activity. Recent filings connect the profile to Neumora Therapeutics, Inc. Common Stock (NMRA) and Metsera, Inc. (MTSR). The current snapshot covers public activity from Dec 27, 2024 to Feb 19, 2026. Reported amounts are shown as $34.5K to $1.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.